Trial Profile
Immunogenicity and Safety of Fluzone Quadrivalent, Southern Hemisphere 2015 Formulation (Intramuscular Route)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Aug 2018
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- Sponsors Sanofi Pasteur
- 12 Jun 2018 New trial record